Cooperative Agreement NU2GGH002328

The Centers for Disease Control and Prevention (CDC) awarded a $8,582,914 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to The Regents of the University of California, San Francisco (UCSF) on September 30, 2024. The award, titled "Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE)", aims to promote sustainable leadership in the political, programmatic, financial, and community realms to...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $8,895,118 to the World Health Organization (WHO) to strengthen public health capacity and guidelines for implementing HIV programs globally. The award period runs from September 30, 2024 to September 29, 2029. The WHO will deliver a range of technical assistance, service delivery, and capacity-building activities focused on preventing new HIV...

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $2,260,212 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Tanzania Commission for AIDS (TACAIDS) to accelerate the coordination of health policy and strategies for HIV/AIDS treatment services in the United Republic of Tanzania. The 5-year project, running from Sep 2024 to Sep 2029, aims to support comprehensive efforts to combat HIV/AIDS globally through the U.S. President's Emergency Plan for...

This $3,371,050 Cooperative Agreement awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) aims to strengthen the delivery of quality and equitable public health services for the prevention, testing, care, and treatment of HIV in Jamaica and Trinidad and Tobago under the President's Emergency Plan for AIDS Relief (PEPFAR). The primary strategies are to: 1) Strengthen comprehensive HIV prevention and testing services for the general...

This $300,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program supports the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project implemented by Humana People To People Congo (HPP-Congo) in Kinshasa, Democratic Republic of the Congo. The project aims to strengthen systematic, people-centered approaches to HIV/TB prevention, detection, and treatment, while improving clinical and community-based services...

This Cooperative Agreement award of $17,185,597.00 from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) aims to strengthen the technical capacity of the Uganda Ministry of Health to standardize, harmonize, and provide oversight for a sustainable public health response to HIV/AIDS, TB, and related health efforts. The 5-year project, commencing on September 30, 2024, will focus on building the ministry's ability to lead and coordinate a...

The Centers for Disease Control and Prevention (CDC) awarded a $15,221,142 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Association Camerounaise Pour LE Marketing Social (ACMS) in Cameroon. The five-year award, beginning September 30, 2024, aims to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon under the President's Emergency Plan for AIDS...

This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $42,680,510 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the Shwari Health Association, a non-profit organization in Cameroon. The 5-year award, which commenced on September 30, 2024, will support the SAFECARE-CAMEROON project to develop, implement, and sustain comprehensive facility and community-based HIV services for children, adolescents, and adults in Cameroon. Key objectives include enhancing the...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $20,980,060 Cooperative Agreement under the Global AIDS Federal Grant Program (CFDA 93.067) to Associacao Centro Pela Saude Global- C - Saude, a non-profit organization in Mozambique. The 5-year award, titled "AVANTE SAUDE", aims to strengthen the Government of Mozambique's capacity to control epidemics in Zambezia Province and improve national health information systems. Key activities include supporting the...